Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras suppressor protein 1 pseudogene 3 (RSU1P3) is a non-coding DNA sequence in the human genome that shares similarity with the Ras suppressor protein 1 gene but is considered a pseudogene, meaning it is generally nonfunctional and unable to produce a functional protein. Pseudogenes often arise from gene duplication or reverse transcription events, followed by disabling mutations, and while most do not encode proteins, some may participate in gene regulation through the production of noncoding RNAs. There is currently no evidence that RSU1P3 serves as a therapeutic target, functions as a biomarker, or interacts with drugs. Like other pseudogenes, it may have regulatory effects on gene expression, but its specific biological or disease roles remain uncharacterized[1][2][3][4][5][6][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras suppressor protein 1 pseudogene 3 (RSU1P3).